chr20-31568206-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_178581.3(HM13):c.1163C>T(p.Pro388Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,612,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178581.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HM13 | NM_178581.3 | c.1163C>T | p.Pro388Leu | missense_variant | 12/13 | ENST00000398174.9 | NP_848696.1 | |
HM13 | NM_178580.3 | c.1163C>T | p.Pro388Leu | missense_variant | 12/13 | NP_848695.1 | ||
HM13 | NM_030789.4 | c.1035-914C>T | intron_variant | NP_110416.1 | ||||
HM13-AS1 | NR_046853.2 | n.248-258G>A | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000525 AC: 13AN: 247404Hom.: 0 AF XY: 0.0000446 AC XY: 6AN XY: 134506
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1460468Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 726536
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2024 | The c.1163C>T (p.P388L) alteration is located in exon 12 (coding exon 12) of the HM13 gene. This alteration results from a C to T substitution at nucleotide position 1163, causing the proline (P) at amino acid position 388 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at